During the past decade, Hospital El Cruce conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital El Cruce" #1 sponsor was "Hospital El Cruce" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "CECILIA CURVALE" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "University of Washington" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital El Cruce" #1 collaborator was "Centro de Informática e Investigación Clínica (CIIC)" with 1 trials as a collaborator, "Children's National Research Institute" with 1 trials as a collaborator, "Ministry of Public Health, Argentina" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Washington State University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital El Cruce" are "Colitis, Ulcerative" (1 trials), "Colorectal Neoplasms" (1 trials), "Esophageal Atresia" (1 trials), "Hereditary Transthyretin-Mediated Amyloid Polyneuropathy" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Hospital El Cruce" in a lesser frequency.

Most popular intervention types in "Hospital El Cruce" are "Drug" (3 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CT" (1 trials), "Combined capsule" (1 trials), "Conventional therapy" (1 trials) and "Eplontersen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital El Cruce" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hospital El Cruce". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital El Cruce, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital El Cruce, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".